We came across a bullish thesis on Insulet Corporation on The Wealth Dynasty Report’s Substack. In this article, we will ...

Insulet Corporation (NASDAQ:PODD) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. As of ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Ahead of the earnings release, Wall Street analysts expect its bottom line to grow. Analysts expect Insulet to report a ...

Insulet stock (NASDAQ: PODD) currently trades around $200 per share, about 35% lower than the levels of over $300 seen in early November 2021. In comparison, its peer – DexCom stock – is down 55% over ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Insulet (PODD) is back on investors’ radar after recent trading pressure, with the share price showing declines over the past week, month and past 3 months that contrast with its underlying business ...

Insulet Corporation (NASDAQ:PODD) reported Q3 sales of $432.7 million, up 27.0%, or 25.1% in constant currency, beating the consensus of $414.383 million. Total Omnipod revenue of $422 million marked ...

(Photo by Kirk Mckoy/Los Angeles Times via Getty Images) When it comes to surgical innovation, Intuitive Surgical (NASDAQ: ISRG) often dominates investor attention. But Insulet Corporation (NASDAQ: ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...